Wright Investors Service’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,124
Closed -$568K 149
2020
Q2
$568K Sell
2,124
-1,077
-34% -$324K 0.22% 109
2020
Q1
$1.01M Sell
3,201
-1,015
-24% -$308K 0.44% 71
2019
Q4
$1.25M Buy
4,216
+569
+16% +$158K 0.43% 73
2019
Q3
$849K Buy
3,647
+1,439
+65% +$335K 0.3% 90
2019
Q2
$517K Buy
2,208
+15
+0.7% +$3.46K 0.2% 106
2019
Q1
$519K Sell
2,193
-834
-28% -$263K 0.21% 103
2018
Q4
$911K Buy
3,027
+19
+0.6% +$6.06K 0.39% 68
2018
Q3
$1.06M Buy
3,008
+12
+0.4% +$4.13K 0.39% 67
2018
Q2
$869K Buy
2,996
+1,928
+181% +$542K 0.35% 76
2018
Q1
$292K Sell
1,068
-704
-40% -$219K 0.1% 161
2017
Q4
$565K Sell
1,772
-2,045
-54% -$656K 0.19% 127
2017
Q3
$1.2M Buy
3,817
+1,439
+61% +$426K 0.43% 62
2017
Q2
$645K Buy
2,378
+163
+7% +$43.1K 0.24% 114
2017
Q1
$606K Buy
2,215
+85
+4% +$24K 0.25% 126
2016
Q4
$604K Buy
+2,130
New +$631K 0.26% 124

Other funds holding BIIB

Wright Investors Service's BIIB Position: Q3 2020 in Review

Wright Investors Service sold out of Biogen (BIIB) in Q3 2020, closing a stake of 2,124 shares — an estimated $568K sold.

Wright Investors Service first reported a position in BIIB in Q4 2016 and held it in 15 quarters. The position peaked at $1.25M in Q4 2019. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Wright Investors Service reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Wright Investors Service sold 2,124 Biogen shares in Q3 2020, an estimated $568K.
  • Wright Investors Service first reported a position in Biogen in Q4 2016 and held it in 15 quarters.
  • Wright Investors Service's Biogen position peaked at $1.25M in Q4 2019.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Wright Investors Service's 13F filing for Q3 2020, filed 6 Nov 2020.